Beckman Research Institute of the City of Hope
City of Hope is an academic cancer research and treatment organization that conducts clinical care, translational research and GMP biologics and cell-product manufacturing. The organization operates immunotherapy-focused clinical trials across a national network, develops adoptive cellular and antibody-based therapies (including CAR T, TIL and NK approaches), integrates genomics and multi-omics with data science for translational analytics, and maintains an FDA-regulated GMP manufacturing facility to support early-phase studies and investigator-initiated programs.
Industries
N/A
Nr. of Employees
small (1-50)
Beckman Research Institute of the City of Hope
Patents
Loop-mediated isothermal amplification devices and systems for detecting genetic material
US-12440844-B2
View DetailsTargeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 positive malignancies
US-12419954-B2
View DetailsTruncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection
US-12421294-B2
View Details
Loop-mediated isothermal amplification devices and systems for detecting genetic material
US-12440844-B2
View DetailsTargeted chimeric antigen receptor modified T cells for treatment of IL13Rα2 positive malignancies
US-12419954-B2
View DetailsTruncated epiderimal growth factor receptor (EGFRt) for transduced t cell selection
US-12421294-B2
View DetailsExpertise Areas
- Immunotherapy and immuno-oncology
- Adoptive cell therapies and apheresis workflows
- Clinical trial management and execution for early-phase studies
- GMP biologics and cellular manufacturing
Key Technologies
- CAR T cell therapy
- Tumor-infiltrating lymphocyte (TIL) therapy
- Natural killer (NK) cell therapy
- Bispecific antibody formats